May 31, 2016 / 7:55 AM / in 3 years

BRIEF-Jazz Pharmaceuticals to acquire Celator Pharmaceuticals for $30.25 per share

May 31 (Reuters) - Celator Pharmaceuticals Inc

* Jazz Pharmaceuticals to acquire Celator for $30.25 per share

* Jazz Pharma expects to finance deal with a combination of cash on hand and borrowings under its senior secured credit facility

* Deal to add Vyxeos, to Jazz Pharmaceuticals’ portfolio

* Deal for about $1.5 billion

* Transaction expected to be accretive to non-gaap adjusted eps beginning in 2018 and beyond for Jazz Pharma

* Jazz Pharmaceuticals and Celator Pharmaceuticals announce agreement for Jazz Pharmaceuticals to acquire Celator for $30.25 per share Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below